Spotlight
Clinical Role
Clinical
Supplement Spotlight
CE
Subscribe
Video
The Impact of PCSK9 Inhibitors on Specialty Pharmacy
Author(s):
Daniel P. Kus, BS Pharm, RPh, vice president of Pharmacy Advantage, discusses the cost implications of pricey cholesterol-lowering PCSK9 inhibitors.
Daniel P. Kus, BS Pharm, RPh, vice president of Pharmacy Advantage, discusses the cost implications of pricey cholesterol-lowering PCSK9 inhibitors.
Related Videos
Related Content
